Grünenthal To Commercialise Duexis With Horizon Pharma

BMI View: Latin America's large population, strong consumer demand, government commitment to economic growth and improvement of the drug regulatory environment make investment in the region's pharmaceutical markets rewarding for many multinational drugmakers. We expect more companies to expand their presence through acquisitions and collaborations in the region.

To read the full article, please choose one of the following options: